Laboratory professional working with samples

Reach more patients. Enable support at scale.

Tucuvi helps pharmaceutical and medical device companies execute patient programs at scale, from early outreach and enrollment to structured follow-up, ongoing support and measurable outcomes.

Trusted by Life Sciences. Proven in real healthcare delivery.
19+
Therapeutic Areas
>90%
Patient Engagement
4.7/5
Patient Satisfaction
+80
Healthcare Organizations Live
+50
Clinical Workflows
CHALLENGES

Reach, engage and support patients.

EVIDENCE ACROSS REAL PROGRAMS

Real programs. Different therapeutic objectives.

At GSK, we are convinced that innovation only matters when it improves people’s lives. That’s why I’m thrilled to share one of those meaningful initiatives announced this summer by the La Rioja Department of Health: ‘Lola calls to get vaccinated’, which uses conversational AI to guide citizens through the vaccination process and boost adult vaccination coverage.
Jorge Pou
Innovation and Commercial Acceleration Director
“This agreement underscores our commitment to leading change and opening new horizons in the approach to different diseases. By integrating Tucuvi’s technology, we can enhance patient monitoring beyond the walls of a healthcare facility. Artificial Intelligence allows us to deliver timely responses while caring for the patient experience.”
César Velasco
Director of Innovation and Digital Strategy
10
Therapeutic Areas deployed
+10k
Patients
42+
Hospitals
96k+
Patient Conversations Across Programs
HOW WE SUPPORT life sicences

Different objectives. One platform to execute them.

Prevention · Patient access · Treatment optimization · Longitudinal care

Healthcare Partnership Programs

Support healthcare provider-led programs developed in collaboration with Life Sciences companies. LOLA® works within healthcare teams' defined workflows to reach eligible patients, collect relevant information and support interventions across prevention, treatment optimization and ongoing care.

  • Expand Screening & Patient Outreach
  • Accelerate Time to Treatment
  • Optimize Treatment

‍

Tucuvi Health Manager: protocols library with population health and pulmonology care plans
Patient recruitment · Enrollment · Retention · PROGRAM-reported data

Clinical Trials

Support clinical research teams with patient outreach, enrollment coordination and structured follow-up throughout the study. LOLA® helps collect patient-reported information, monitor participation and identify cases requiring attention, following predefined study protocols.

  • Support Patient Recruitment & Enrollment
  • Improve Participant Engagement & Retention
  • Capture Structured Patient-Reported Data

‍

LOLA call in progress with a patient: inbound voice, outbound voice and SMS
Patient onboarding · Treatment education · Adherence · Persistence

Patient Support Programs

Support patients throughout medication and medical device programs, from initial onboarding to ongoing treatment and follow-up. LOLA® engages patients through accessible, structured conversations, helping them understand program steps, share treatment experiences, identify barriers to adherence and persistence, and connect with support teams when needed.

  • Simplify Enrollment & Onboarding
  • Improve Treatment Adherence
  • Support Therapeutic Persistence

‍

Tucuvi Dashboard with patients engaged, alerts and patients for review
aaa

fff

fff

SECURITY

Trust Center

ENS High, ISO 27001, GDPR, data processing and ownership.

SECURITY

Trust Center

ENS High, ISO 27001, GDPR, data processing and ownership.

SECURITY

Trust Center

ENS High, ISO 27001, GDPR, data processing and ownership.

EXPERTISE

Wide range of therapeutic areas

BENEFITS

Reach, engage and support patients, safely and at scale

Patient Identification, access & enrollment

Identify and reach eligible patient populations, supporting access to care, clinical trial enrollment and onboarding into treatment or device programs.

Patient Engagement & Continuity

‍

Keep patients engaged throughout treatment, clinical research and long-term follow-up. Identify barriers, unmet needs and situations requiring professional support.

Measurable Program Impact

Capture aggregated patient-reported information and program data to measure participation, completion, treatment continuity and other program-specific outcomes.

Clinical Safety & Compliance

Run patient-facing programs as a CE-marked Class IIb medical device that meets globally recognized standards, within an approved scope, with human oversight, data protection and traceability built into every interaction.

WHO WE HELP

Built for Life Sciences

Patient programs depend on staying in contact with each patient at the right moment. LOLA holds those conversations at scale and returns structured data to marketing, market access, medical affairs and clinical teams.

‍

Patient record in the Tucuvi platform
https://vimeo.com/1239799044/3568290c9a?share=copy&fl=sv&fe=ci
At GSK, we are convinced that innovation only matters when it improves people’s lives. That’s why I’m thrilled to share one of those meaningful initiatives announced this summer by the La Rioja Department of Health: ‘Lola calls to get vaccinated’, which uses conversational AI to guide citizens through the vaccination process and boost adult vaccination coverage.
Jorge Pou
Innovation and Commercial Acceleration Director
WHY CHOOSE US

.

Time to Treatment
Help patients access timely assessments and interventions by identifying unmet needs and facilitating earlier clinical action.
Optimize Treatment
Capture patient-reported symptoms and treatment response to help care teams identify opportunities to review and adjust therapies.
Support Therapeutic Persistence
Help patients stay on therapy for longer by identifying side effects and treatment barriers before they lead to discontinuation.
Improve Treatment Adherence
Help patients follow prescribed treatments through proactive reminders, regular follow-up and personalized support.
Expand Screening & Patient Outreach
Reach more eligible patients, encourage participation in prevention and screening programs, and facilitate access to care.
Simplify Enrollment & Onboarding
Help patients follow prescribed treatments through proactive reminders, regular follow-up and personalized support.
MEANINGFUL PATIENT & CLINICAL DATA

Turn program activity into information that supports better decisions.

Tucuvi Data gives Life Sciences partners aggregated program data through a secure dashboard portal. Each program’s KPIs are defined and validated before launch, combining clinical actions, patient responses and baseline data, so results can be followed over time, compared across projects and reported with confidence.

Defined Indicators

Establish what will be measured, how each KPI is defined and which data sources will be used.

Program Performance

Track patient reach, engagement, completed steps, incomplete activities and other agreed program metrics.

Anonimyzed Program Reports

Capture relevant symptoms, adverse events, PROs, PREMs and cases requiring professional follow-up, where included in the defined program.

Clinically governed AI for patient programs.
CE
ISO 13485
ISO 27001
GDPR
ENS

Frequently Asked Questions

How does Tucuvi support pharmaceutical companies and Life Sciences organizations?

Tucuvi helps Life Sciences companies enable timely, scalable contact with patients across the entire care pathway through an AI Care Management Platform. Through structured, protocol-based conversations at each clinical stage, from identification and diagnosis to treatment initiation and long-term follow-up, Tucuvi helps healthcare teams reduce delays, prioritise patients who need attention and optimise the pathway at every level of care.

What types of Patient Support Programs can Tucuvi manage?

Patient Support Programs are one of the many ways Tucuvi collaborates with Life Sciences companies. Within these programs, Tucuvi supports onboarding, patient education, treatment follow-up, questionnaires, information requests and adherence-related workflows. Programs can be configured around specific patient needs and responsibilities, with appropriate healthcare professional oversight.

Can Tucuvi improve medication adherence and treatment persistence?

Patients often become non-adherent because they lack timely reminders, or simply because they feel well enough to believe they no longer need to take their medication as prescribed. This is why timely follow-up plays a key role in supporting adherence. Tucuvi helps identify symptoms, treatment barriers and unmet needs that may affect continuity. Patient-reported information is structured to support professional follow-up. Improvements in adherence or persistence must be demonstrated with program-specific data.

Can Tucuvi support new patient starts and treatment optimization?

Tucuvi can support healthcare-led outreach and follow-up programs designed to help patients progress through treatment pathways. Eligibility and prescribing decisions remain with clinical teams. Commercial outcomes such as new patient starts require specific measurement.

What is the difference between Tucuvi's Patient Support Programs and healthcare partnerships?

Patient Support Programs focus on treatment-related needs such as onboarding and adherence. In these programs, LOLA® carries out structured follow-up from outside the hospital, so healthcare professionals do not have to perform these activities themselves. Healthcare partnerships support broader clinical objectives, including prevention, treatment optimization and longitudinal care. In these partnerships, LOLA®, Tucuvi's Clinical Voice AI, becomes part of the hospital's clinical team, and all calls are managed from within the clinical department itself. Tucuvi can support both through configurable workflows.

How does LOLA® support patient engagement in pharmaceutical programs?

LOLA®, Tucuvi's Clinical Voice AI, enables natural telephone conversations across a wide range of program activities, including onboarding, questionnaires, identification of potentially underdiagnosed patients, symptom monitoring, adverse event follow-up, and support for medication adherence and treatment persistence, among others. All of this is managed through the simplest channel for patients, a phone call, which helps achieve high patient reach and engagement rates. Responses are structured within Tucuvi Health Manager to support program execution and identify cases requiring attention.

Can Tucuvi support clinical trials and real-world evidence generation?

LOLA® is designed to act as a primary patient-facing data collection tool in clinical trials, covering critical points across the study, such as patient identification and enrollment (often a key cause of delays in study execution), disease monitoring, reminders, patient-reported outcomes, appointment scheduling, adverse event follow-up and safety surveillance. Tucuvi is also designed to integrate with the information systems typically involved in a clinical trial.

How does Tucuvi measure Patient Support Program outcomes and ensure compliance?

Tucuvi Health Manager supports indicators such as patient reach, engagement, completed follow-ups, reported symptoms and other program-defined outcomes. Each program operates within agreed clinical, data protection and regulatory responsibilities. LOLA® is a Software as a Medical Device (SaMD), CE-marked as a Class IIb medical device under the EU Medical Device Regulation (MDR). Tucuvi complies with GDPR, is certified under ISO 27001 for information security, and meets the requirements of Spain's National Security Framework (ENS). Data is hosted on Google Cloud Platform in EU regions.

No items found.

Turn patient programs into continuous support and measurable impact.

Extend patient reach, execute defined care workflows and generate the information needed to understand program performance.